These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 17279376

  • 1. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
    Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH.
    Psychopharmacology (Berl); 2007 May; 192(1):61-70. PubMed ID: 17279376
    [Abstract] [Full Text] [Related]

  • 2. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA, Kaiser N, Monory K, Lutz B.
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [Abstract] [Full Text] [Related]

  • 3. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 4. Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus.
    Schlosburg JE, Boger DL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Apr; 329(1):314-23. PubMed ID: 19168707
    [Abstract] [Full Text] [Related]

  • 5. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C.
    Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [Abstract] [Full Text] [Related]

  • 8. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2008 Dec 14; 600(1-3):50-8. PubMed ID: 18762181
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
    Hoyer FF, Khoury M, Slomka H, Kebschull M, Lerner R, Lutz B, Schott H, Lütjohann D, Wojtalla A, Becker A, Zimmer A, Nickenig G.
    J Mol Cell Cardiol; 2014 Jan 14; 66():126-32. PubMed ID: 24286707
    [Abstract] [Full Text] [Related]

  • 10. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
    Haller J, Barna I, Barsvari B, Gyimesi Pelczer K, Yasar S, Panlilio LV, Goldberg S.
    Psychopharmacology (Berl); 2009 Jul 14; 204(4):607-16. PubMed ID: 19259645
    [Abstract] [Full Text] [Related]

  • 11. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
    Justinova Z, Mangieri RA, Bortolato M, Chefer SI, Mukhin AG, Clapper JR, King AR, Redhi GH, Yasar S, Piomelli D, Goldberg SR.
    Biol Psychiatry; 2008 Dec 01; 64(11):930-7. PubMed ID: 18814866
    [Abstract] [Full Text] [Related]

  • 12. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Sep 01; 330(3):902-10. PubMed ID: 19502530
    [Abstract] [Full Text] [Related]

  • 13. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
    Kwilasz AJ, Abdullah RA, Poklis JL, Lichtman AH, Negus SS.
    Behav Pharmacol; 2014 Apr 01; 25(2):119-29. PubMed ID: 24583930
    [Abstract] [Full Text] [Related]

  • 14. The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats.
    Haller J, Goldberg SR, Pelczer KG, Aliczki M, Panlilio LV.
    Psychopharmacology (Berl); 2013 Dec 01; 230(3):353-62. PubMed ID: 23743650
    [Abstract] [Full Text] [Related]

  • 15. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
    Moise AM, Eisenstein SA, Astarita G, Piomelli D, Hohmann AG.
    Psychopharmacology (Berl); 2008 Oct 01; 200(3):333-46. PubMed ID: 18545985
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
    Li H, Wood JT, Whitten KM, Vadivel SK, Seng S, Makriyannis A, Avraham HK.
    Br J Pharmacol; 2013 Oct 01; 170(3):489-505. PubMed ID: 23347118
    [Abstract] [Full Text] [Related]

  • 17. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov 01; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

  • 18. Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.
    Bambico FR, Cassano T, Dominguez-Lopez S, Katz N, Walker CD, Piomelli D, Gobbi G.
    Neuropsychopharmacology; 2010 Sep 01; 35(10):2083-100. PubMed ID: 20571484
    [Abstract] [Full Text] [Related]

  • 19. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM, Guindon J, Hohmann AG.
    Pharmacol Res; 2010 Sep 01; 62(3):249-58. PubMed ID: 20416378
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).
    Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D.
    CNS Drug Rev; 2006 Sep 01; 12(1):21-38. PubMed ID: 16834756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.